These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6177009)

  • 1. The possible role of circulating 6-oxo-PGF1 alpha in monitoring the growth and spread of malignant disease of the prostate.
    Hensby CN; Khan QM; Williams G; Dollery CT
    Prog Lipid Res; 1981; 20():681-3. PubMed ID: 6177009
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
    J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of GC-MS and RIA methods for 6-oxo-PGF1 alpha.
    Hensby CN; Jogee M; Myatt L
    Prog Lipid Res; 1981; 20():779-82. PubMed ID: 6896236
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostacyclin is not a circulating hormone in man.
    Blair IA; Barrow SE; Waddell KA; Lewis PJ; Dollery CT
    Prostaglandins; 1982 Apr; 23(4):579-89. PubMed ID: 7051184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comment on Grond, A., M. Ostermann-Myrau: Benign and malignant diseases of the prostate].
    Grond A
    Versicherungsmedizin; 1995 Apr; 47(2):66-7. PubMed ID: 7539193
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostacyclin concentrations in cord blood and in the newborn.
    Jacqz EM; Barrow SE; Dollery CT
    Pediatrics; 1985 Dec; 76(6):954-7. PubMed ID: 3906549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry.
    Hensby CN; Fitzgerald GA; Friedman LA; Lewis PJ; Dollery CT
    Prostaglandins; 1979 Nov; 18(5):731-6. PubMed ID: 396578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral plasma immunoreactive 6-oxo-prostaglandin F1 alpha and gynaecological tumours.
    Alam M; Jogee M; MacGregor WG; Dowdell JW; Elder MG; Myatt L
    Br J Cancer; 1982 Mar; 45(3):384-9. PubMed ID: 6896152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of 6-Oxo-PGF1 alpha in biological fluids by gas chromatography mass spectrometry.
    Claeys M; Van Hove C; Duchateau A; Herman AG
    Biomed Mass Spectrom; 1980 Nov; 7(11-12):544-8. PubMed ID: 6894397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific quantitative determination of 6-oxo-prostaglandin F1 alpha in human plasma.
    Blair IA; Barrow SE; Waddell KA; Lewis PJ; Dollery CT
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():197-205. PubMed ID: 6221526
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].
    Pushkar' DIu; Rasner PI; Skobelev PP
    Urologiia; 2001; (6):48-54. PubMed ID: 11785083
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha.
    Pedersen AK; Watson ML; FitzGerald GA
    Thromb Res; 1984 Jan; 33(1):99-103. PubMed ID: 6546456
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostacyclin in prostatic cancer: a better marker than bone scan or serum acid phosphatase?
    Khan O; Hensby CN; Williams G
    Br J Urol; 1982 Feb; 54(1):26-31. PubMed ID: 7037104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage A prostate cancer today.
    Kabalin JN
    J Urol; 1993 Nov; 150(5 Pt 2):1749-50. PubMed ID: 7692113
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of prostanoid metabolites by gas chromatography/mass spectrometry.
    Frölich JC; Rosenkranz B; Fejes-Tóth G; Naray-Fejes-Tóth A; Frölich B
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():47-52. PubMed ID: 2936145
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased plasma-6-oxo-PGF1-alpha but normal PGI2 half-life in patients with maxillo-facial tumors.
    Porteder H; Matejka M; Kment G; Nell A; Sinzinger H
    Prog Clin Biol Res; 1987; 242():123-9. PubMed ID: 3313409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane and 6-oxo-PGF1 alpha in the plasma of patients with diabetes type I and II.
    Rösen P; Hohl C; Tschöpe D; Körner A; Halfmann U; Berger M
    Prog Clin Biol Res; 1987; 242():247-52. PubMed ID: 3671386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of calcitonin and 6-oxo-prostaglandin Fl alpha in the differentiation of lung cancers].
    Burghuber OC; Kovarik J; Woloszczuk W; Sehnal E; Sinzinger H; Weissel M
    Acta Med Austriaca; 1987; 14(2):47-50. PubMed ID: 2820176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin and thromboxane in non-insulin dependent diabetes: the chlorpropamide alcohol flush reaction revisited.
    Johnston C; Carey F; Forder RA; Haworth D
    Clin Sci (Lond); 1984 Dec; 67(6):633-8. PubMed ID: 6548428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
    Urologiia; 2001; (2):37-40. PubMed ID: 11490716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.